T cell therapy, a type of immunotherapy that leverages the immune system to combat diseases, is a powerful treatment option ...

Century Therapeutics (IPSC) aims at a durable “once-and-done” Type 1 diabetes cure with hypoimmune iPSC beta cells; runway to ...

naturopathic medicine, functional medicine, integrative medicine, thymosin alpha-1, immunosenescence, thymic involution, inflammaging, peptide therapy ...

Researchers are exploring a transplant approach that combines lab-made beta cells with engineered immune “bodyguards” to help them survive in type 1 diabetes. The goal is to restore insulin production ...

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold new front. With $1 million in funding from Breakthrough T1D, the ...

Herbert Bravo, MD, and Marian Rewers, MD, PhD, explored how C-peptide preservation reshaped both clinical management and economic considerations in type 1 diabetes. In episode 4 of the Special Report: ...

At December’s Cell and Gene Therapy International Europe event, developer NextCell discussed how its research using mesenchymal stem cells (MSCs) could change the treatment landscape for type 1 ...

BUENOS AIRES, Dec. 4 (UPI) --Argentine scientists have identified a mechanism that allows pancreatic beta cells, which produce insulin, to become resistant to damage. The finding opens the door to new ...

Explore groundbreaking therapies for type 1 diabetes that aim to delay onset, preserve β-cell function, and restore insulin independence. Type 1 diabetes (T1D) is an idiopathic, autoimmune disease ...

Autoantibodies for type 1 diabetes are markers of the immune system’s attack on beta cells. Testing for these autoantibodies – GAD, IA-2, IAA, ZnT8, and ICA – can help with monitoring and preparing ...